Target intelligence / Profile preview

ribosomal protein L23a pseudogene 31 (RPL23AP31)

Target
RPL23AP31
Molecular classification
Other (Pseudogene), Non-coding RNA (processed pseudogene)
01

Overview

RPL23AP31 is a processed pseudogene of ribosomal protein L23a, located on human chromosome 2 (GRCh38: CM000664.2, 2:218,841,599-218,842,065) and does not encode a functional protein[4]. Pseudogenes like RPL23AP31 are segments of DNA similar to normal genes but typically non-functional due to mutations, deletions, or the absence of regulatory elements required for gene expression. While some ribosomal protein L23a pseudogenes have shown differential expression and potential association with cancer biology or immune response (e.g., RPL23AP53 in melanoma)[2], RPL23AP31 itself has not been specifically implicated as a functional molecule, biomarker, or therapeutic target.

Other names
RPL23A_13_326RPL23AP31
02

Biological functions

Other (No known protein-coding function; presumed non-coding RNA, if transcribed)
03

Disease associations

Other (No direct evidence for involvement in disease; other ribosomal protein L23a pseudogenes have been explored as biomarkers or for diagnostic utility in some cancers such as melanoma but not specifically RPL23AP31)

Beyond the preview

Go deeper on ribosomal protein L23a pseudogene 31 (RPL23AP31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L23a pseudogene 31 (RPL23AP31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call